Photo of Aneesh Bhim Singhal, MD

Aneesh Bhim Singhal, MD

  • Vice Chair, Department of Neurology


Accepting New Patients




Centers & Specialties

Vascular Center

Clinical Interests
  • Stroke
  • Reversible Cerebral Vasoconstriction Syndromes
  • Stroke neuroimaging
  • Stroke in young adults
  • Less common causes of stroke
Medical Education
  • MD, Seth G. S. Medical College University of Mumbai
  • Residency, BYL Nair Hospital|Residency, Massachusetts General Hospital
Board Certifications
  • Neurology
  • Vascular Neurology
  • Boston: Massachusetts General Hospital
  • Charlestown: Spaulding Rehabilitation Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Connecticut
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
  • United Healthplan (non-HMO) - SSN
Patient Age Group

Edit Profile


Dr. Aneesh B. Singhal is a Board Certified Neurologist, Vascular Neurologist, Neurosonologist, and Chair of Quality and Safety for the Departmet of Neurology.

Dr. Singhal's key research interests are in stroke neuroprotection, stroke neuroimaging, and "uncommon causes of stroke' including reversible cerebral vasoconstriction syndrome (RCVS) and cerebral vasculitis.

Dr. Singhal has conducted previous and ongoing studies in both animals and humans to investigate the therapeutic potential of Normobaric oxygen therapy (NBO) as a strategy that can extend the 3-hour time window for tissue plasminogen activator (tPA), which is the only FDA-approved acute stroke treatment. He is involved in several NIH funded studies aimed at developing new CT and MR imaging techniques for ischemic stroke and migraine. Additionally he conducts prospective and retrospective analytical studies aimed at understanding stroke mechanisms and correlating stroke neuroimaging with etiology. In addition to his academic responsibilities, he serves as a grant reviewer for the NIH and other scientific organizations and conducts journal manuscript reviews.

Dr. Singhal, born in Mumbai, India, brings a key strength to the department. His interest in promoting stroke care at the international level, in addition to his strong relationship with key investigators in India has proved to be successful in breaking the international barrier and standardizing stroke management. He is a key player in organizations such as the 'Association of Indian Neurologists in America', the World Foundation of Neurology', the 'Heal Foundation' (India), and serves as International Advisor to the Indian Stroke Association.

Edit Profile

Research & Publications

Please click on the link below[author

Edit Profile

News & Events



Neurology & Stroke Services
15 Parkman Street
Boston MA, 02114-3117
Phone: 617-726-8459
Fax: 617-726-5043
Spaulding Rehabilitation Hospital
300 First Avenue
Charlestown MA, 02129-3109
Phone: 617-573-7000

Edit Profile

Back to Top